Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
With
Emergent Product Development Seattle LLC
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Meets the American College of Rheumatology (ACR) 1987 revised criteria for classification of Rheumatoid Arthritis (RA) for at least 6 months prior to screening
Active RA as defined by \>= 5 swollen and \>= 5 tender joints (28-joint count) and at least 1 of the following: C-reactive protein \>= 10 mg/L or Erythrocyte Sedimentation Rate \>= 28 mm/h
Must be seropositive as defined by a documented history of rheumatoid factor (RF) or anti-cyclic citrullinated peptide (anti-CCP) positivity
Must be receiving a stable route and dose of methotrexate (up to 25 mg weekly)
You may not be if
Any significant health problem other than rheumatoid arthritis
Any clinically significant laboratory abnormalities
Any prior use of B cell-depleting therapy
Clareo Health | Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis
